Piperidine derivatives and pharmaceutical compositions containing them
    8.
    发明授权
    Piperidine derivatives and pharmaceutical compositions containing them 失效
    哌啶衍生物和含有它们的药物组合物

    公开(公告)号:US4551465A

    公开(公告)日:1985-11-05

    申请号:US565902

    申请日:1983-12-27

    CPC分类号: C07D295/088

    摘要: The invention relates to new piperidine derivatives of the formula (I) ##STR1## wherein R.sub.1 is halogen, trihalomethyl, alkyl having from one to 4 carbon atoms or alkoxy having from one to 4 carbon atoms; andR.sub.2 is hydrogen or alkyl having from one to 4 carbon atoms, and acid addition and quaternary ammonium salts thereof. According to another aspect of the invention there are provided processes for the preparation of these compounds. The compounds of the formula (I) are pharmacologically active. In particular, they inhibit the microsomal monooxigenase enzyme system of the liver. Pharmaceutical compositions containing them as active ingredient are also within the scope of the invention.

    摘要翻译: 本发明涉及式(I)的新的哌啶衍生物:其中R 1是卤素,三卤代甲基,具有1至4个碳原子的烷基或具有1至4个碳原子的烷氧基; 并且R 2为氢或具有1至4个碳原子的烷基,及其酸加成盐和季铵盐。 根据本发明的另一方面,提供了这些化合物的制备方法。 式(I)的化合物具有药理活性。 特别地,它们抑制肝脏的微粒体单致原子酶系统。 含有它们作为活性成分的药物组合物也在本发明的范围内。